UVA Health System will lead a clinical trial, called Stroke Hyperglycemia Insulin Network Effort (SHINE), involving more than 50 centers across the country. Researchers will study whether controlling diabetic stroke patients’ blood sugar in the early period after stroke is an effective treatment.
Read the health system release on the $25 million NIH grant.
Related Articles on Hospital Neurology:
Mayo Clinic Receives $10M to Participate in Neurology, Cardiovascular Studies
Arizona’s Banner Thunderbird Adds First Pediatric Neurologist
Pittsburgh’s Allegheny General to Begin Admitting Patients to Neurosurgical ICU
